Medical Devices Ordinance
(MedDO)


Open article in different language:  DE  |  FR  |  IT
Art. 103 Devices incorporating devitalised tissues or cells of human origin

1 Devices in­cor­por­at­ing de­vi­tal­ised tis­sues or cells of hu­man ori­gin or their de­riv­at­ives as spe­cified in Art­icle 1 para­graph 3 let­ters c no. 2 and d that were law­fully placed on the mar­ket or put in­to ser­vice pri­or to 26 May 2021 may con­tin­ue to be made avail­able on the mar­ket or put in­to ser­vice un­til 26 May 2025. Art. 101 para­graph 2 ap­plies mu­tatis mutandis.

2 Un­til such time as a cor­res­pond­ing spe­cial Or­din­ance is is­sued, devices covered by Art­icle 2a para­graph 2 TPA are sub­ject to the Med­ic­al Devices Or­din­ance of 17 Oc­to­ber 2001139. Devices covered by Art­icle 2a para­graph 2 TPA that were law­fully placed on the mar­ket pri­or to 26 May 2021 may con­tin­ue to be made avail­able on the mar­ket or put in­to ser­vice un­til such time as a cor­res­pond­ing spe­cial Or­din­ance is is­sued.

139 See the foot­note to Art. 99 no 1.

Previous article Show article in the law Next article

Diese Seite ist durch reCAPTCHA geschützt und die Google Datenschutzrichtlinie und Nutzungsbedingungen gelten.

Feedback
Gesetzeskürzel Name
DE FR IT EN
DE FR IT EN
Laden